- "Study of molecular predictors of patients with: 1. glioma tumors 2. non small cell lung cancer"Publication without faculty affiliation
- Molecular and IHC analysis of head and neck carcinomas associated with HPV infection2019 | First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
- Individualized therapy in non small cell lung Cancer (NSCLC)2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Personalised targeted treatment of non-small cell lung carcinomas as a clinical reality2013 | First Faculty of Medicine
- Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib2016 | Faculty of Medicine in Pilsen, Faculty of Science
- Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome2011 | Second Faculty of Medicine
- RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS2022 | First Faculty of Medicine, Faculty of Science
- High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib2015 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Science